Market closed· · CHF · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Galenica Ltd (WBO:GALE) delivers 7.1% sales growth and reaffirms 2026 guidance, leveraging healthcare services expansion and LaborTeam synergies despite a flat OTC market and regulatory pressures.
Key Insights The considerable ownership by retail investors in Galenica indicates that they collectively have a greater...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.